Skip To Main Content
Jinying Ning on Muck Rack

Jinying Ning

As seen in: PLOS ONE, Dentistry Uncensored with Howard Farran
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jinying

Contact Jinying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PBMC Humanized Mouse Models: Studying Human Immune Responses in Translational Oral Research

|
By Jinying Ning
| Dentistry Uncensored with Howard Farran
PBMC Humanized Mouse Models: Studying Human Immune Responses in Translational Oral Research By Jinying Ning, Ph.D. Understanding human immune responses within living tissue remains one of the most complex challenges in biomedical research. In dentistry, this challenge is especially relevant to periodontal inflammation, peri-implant disease, and oral oncology, where immune mechanisms directly influence tissue destruction, tumour progression, and therapeutic outcomes [1,2].
Open in Who Shared Issue with article?

Neutralizing antibody against GDF15 for treatment of cancer-associated cachexia

|
By Guojin Wu, Kyinno Biotechnology co, Junyi Xiong, Jinying Ning
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Xiong J, Wu G, Ning J, Yan J, Yang J, Kang J (2024) Neutralizing antibody against GDF15 for treatment of cancer-associated cachexia. PLoS ONE 19(8): e0309394. https://doi.org/10.1371/journal.pone.0309394 Editor: Clive J. Petry, University of Cambridge, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND Received: January 16, 2024; Accepted: August 5, 2024; Published: August 22, 2024 Copyright: © 2024 Xiong et al.
Open in Who Shared Issue with article?
See all 2 articles